Skip to main content

Table 2 General nutritional and biochemical indicator measurements of the two groups of ALL patients at the end of the 1st、2nd、3rd and the 4th week (x ± s)

From: Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia

Parameters

n

ALB (g/L)

PA (mg/L)

RBP (mg/L)

UHI

CHI

Treatment group

24

     

 Before treatment

 

29.45 ± 2.87

106.6 ± 21.58

19.56 ± 1.78

1.38 ± 0.48

75.96 ± 11.69

  At the end of 1st week

 

29.34 ± 3.53

107.5 ± 22.47

19.42 ± 1.94

1.39 ± 0.55

76.21 ± 12.15

  At the end of 2nd week

 

28.69 ± 2.72

113.47 ± 20.56a

21.76 ± 1.89a

1.35 ± 0.51

72.54 ± 13.21

  At the end of 3rd week

 

30.78 ± 2.75a

130.52 ± 22.31a

22.34 ± 2.15a

1.42 ± 0.55a

75.88 ± 14.16

  At the end of 4th week

 

32.57 ± 3.05a

145.71 ± 23.25a

24.59 ± 5.30a

1.49 ± 0.57a

78.22 ± 14.57

Control group

24

     

 Before treatment

 

29.34 ± 3.67

111.78 ± 21.23

20.57 ± 2.32

1.29 ± 0.51

75.79 ± 12.33

  At the end of 1st week

 

29.11 ± 3.42

110.44 ± 20.54

20.13 ± 2.02

1.28 ± 0.46

75.59 ± 12.08

  At the end of 2nd week

 

28.77 ± 3.09

100.85 ± 19.78

19.78 ± 2.11

1.26 ± 0.41

73.14 ± 12.79

  At the end of 3rd week

 

26.90 ± 3.54

112.62 ± 20.01

20.05 ± 2.52

1.15 ± 0.38

72.21 ± 12.58

  At the end of 4th week

 

27.15 ± 3.29

110.57 ± 21.22

19.52 ± 2.49

1.18 ± 0.36

72.75 ± 12.93

  1. acompared with control group, P < 0.05